Annual EBIT
$311.00M$72.80M-18.97%
Summary
- Current Value
- As of today, BIO annual EBIT is $311.00M, down -18.97% on
- Historical Performance
- BIO annual EBIT is down -44.93% over the past 3 years, and up +22.46% over the past 5 years
- All-Time High Comparison
- BIO annual EBIT is currently -44.93% below its historical high of $564.74M set on
- 3-Year Low Comparison
- BIO annual EBIT is at its 3-year low
- Sector Comparison
- BIO annual EBIT is higher than 91.12% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $311.00M | -19.0% | -44.9% | +22.5% | +32.5% | |
| Quarterly EBIT | $66.40M | -29.6% | -29.8% | -39.3% | -11.2% | |
| TTM EBIT | $287.60M | -16.5% | -41.8% | -11.5% | +8.0% | |
| Price | $324.09 | -5.9% | -22.6% | -47.8% | +208.4% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.57B | -3.9% | -12.2% | +11.0% | +43.8% | |
| Annual EPS | -$65.36 | -199.6% | -146.4% | -212.2% | -1357.0% | |
| Annual EBITDA | $503.80M | -12.6% | -32.1% | +17.6% | +49.7% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $479.32M | N/A | -35.1% |
| 5Y | $564.74M | -44.9% | |
| All | $564.74M | -44.9% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $311.00M | at low | |
| 5Y | $311.00M | at low | |
| All | -$401.00K | >+9999.0% |
EBIT History
FAQ
What is the current annual EBIT of BIO?
As of today, BIO annual EBIT is $311.00M
What is 1-year change in BIO annual EBIT?
BIO annual EBIT is down -18.97% year-over-year
What is 3-year change in BIO annual EBIT?
BIO annual EBIT is down -44.93% over the past 3 years
How far is BIO annual EBIT from its all-time high?
BIO annual EBIT is currently -44.93% below its historical high of $564.74M set on December 31, 2021
How does BIO annual EBIT rank versus sector peers?
BIO annual EBIT is higher than 91.12% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly EBIT
$66.40M$13.10M-16.48%
Summary
- Current Value
- As of today, BIO quarterly EBIT is $66.40M, down -16.48% on
- Historical Performance
- BIO quarterly EBIT is down -29.64% year-over-year, and down -29.84% over the past 3 years
- All-Time High Comparison
- BIO quarterly EBIT is currently -62.37% below its historical high of $176.46M set on
- 3-Year Low Comparison
- BIO quarterly EBIT is +27.67% above its 3-year low of $52.01M reached on
- Sector Comparison
- BIO quarterly EBIT is higher than 90.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $66.40M | -16.5% | -29.6% | -29.8% | -39.3% | |
| Annual EBIT | $311.00M | – | -19.0% | -44.9% | +22.5% | |
| TTM EBIT | $287.60M | -8.9% | -16.5% | -41.8% | -11.5% | |
| Price | $324.09 | +7.0% | -5.9% | -22.6% | -47.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $653.00M | +0.2% | +0.5% | -4.1% | +0.9% | |
| Quarterly EPS | -$12.70 | -208.8% | -154.4% | -131.9% | -129.1% | |
| Quarterly EBITDA | $120.60M | -7.3% | -15.9% | -13.1% | -20.7% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $84.80M | N/A | -21.7% |
| 3Y | $111.35M | -40.4% | |
| 5Y | $176.46M | -62.4% | |
| All | $176.46M | -62.4% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $56.90M | +16.7% | |
| 3Y | $52.01M | +27.7% | |
| 5Y | $52.01M | +27.7% | |
| All | -$125.80M | +152.8% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of BIO?
As of today, BIO quarterly EBIT is $66.40M
What is BIO quarterly EBIT most recent change?
BIO quarterly EBIT was down -16.48% on September 30, 2025
What is 1-year change in BIO quarterly EBIT?
BIO quarterly EBIT is down -29.64% year-over-year
How far is BIO quarterly EBIT from its all-time high?
BIO quarterly EBIT is currently -62.37% below its historical high of $176.46M set on March 31, 2021
How does BIO quarterly EBIT rank versus sector peers?
BIO quarterly EBIT is higher than 90.01% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM EBIT
$287.60M$27.97M-8.86%
Summary
- Current Value
- As of today, BIO TTM EBIT is $287.60M, down -8.86% on
- Historical Performance
- BIO TTM EBIT is down -16.51% year-over-year, and down -41.82% over the past 3 years
- All-Time High Comparison
- BIO TTM EBIT is currently -53.48% below its historical high of $618.29M set on
- 3-Year Low Comparison
- BIO TTM EBIT is at its 3-year low
- Sector Comparison
- BIO TTM EBIT is higher than 89.83% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $287.60M | -8.9% | -16.5% | -41.8% | -11.5% | |
| Annual EBIT | $311.00M | – | -19.0% | -44.9% | +22.5% | |
| Quarterly EBIT | $66.40M | -16.5% | -29.6% | -29.8% | -39.3% | |
| Price | $324.09 | +7.0% | -5.9% | -22.6% | -47.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.56B | +0.1% | -0.9% | -8.8% | +7.5% | |
| TTM EPS | -$24.31 | -307.1% | +11.1% | +87.9% | -120.8% | |
| TTM EBITDA | $489.90M | -4.5% | -9.4% | -28.6% | -1.6% | |
| TTM Net Income | -$675.90M | -311.8% | +13.2% | +88.8% | -119.2% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $336.36M | -14.5% | |
| 3Y | $474.72M | N/A | -39.4% |
| 5Y | $618.29M | -53.5% | |
| All | $618.29M | -53.5% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $287.60M | at low | |
| 3Y | $287.60M | at low | |
| 5Y | $287.60M | at low | |
| All | -$59.90M | +580.1% |
TTM EBIT History
FAQ
What is the current TTM EBIT of BIO?
As of today, BIO TTM EBIT is $287.60M
What is BIO TTM EBIT most recent change?
BIO TTM EBIT was down -8.86% on September 30, 2025
What is 1-year change in BIO TTM EBIT?
BIO TTM EBIT is down -16.51% year-over-year
How far is BIO TTM EBIT from its all-time high?
BIO TTM EBIT is currently -53.48% below its historical high of $618.29M set on September 30, 2021
How does BIO TTM EBIT rank versus sector peers?
BIO TTM EBIT is higher than 89.83% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
EBIT Formula
EBIT = − −
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio